Your browser doesn't support javascript.
loading
Recombinant human erythropoietin reduces plasminogen activator inhibitor and ameliorates pro-inflammatory responses following trauma
M., Shiehmorteza; A., Ahmadi; M., Abdollahi; M., Nayebpour; M., Mohammadi; H., Hamishehkar; A., Najafi; M., Pazoki; M, Mojtahedzadeh.
DARU-Journal of Faculty of Pharmacy Tehran University of Medical Sciences. 2011; 19 (2): 159-165
in En | IMEMR | ID: emr-129757
Responsible library: EMRO
Subject(s)
Search on Google
Add to My VHL
Print
XML
Index: IMEMR Main subject: Wounds and Injuries / Treatment Outcome / Plasminogen Activator Inhibitor 1 / Inflammation / Anti-Inflammatory Agents / Antioxidants Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: J. Fac. Pharm. Tehran Univ. Med. Sci. Year: 2011
Search on Google
Add to My VHL
Print
XML
Index: IMEMR Main subject: Wounds and Injuries / Treatment Outcome / Plasminogen Activator Inhibitor 1 / Inflammation / Anti-Inflammatory Agents / Antioxidants Type of study: Clinical_trials Limits: Adult / Humans / Male Language: En Journal: J. Fac. Pharm. Tehran Univ. Med. Sci. Year: 2011